Clinical trials
Phase 1/2 Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cordis US Corp. | 5 |
| University Hospital, Saarland | 3 |
| Abbott Medical Devices | 1 |
| Ain Shams University | 1 |
| Alexandra Cristina Senegaglia | 1 |
| Biotronik AG | 1 |
| C. R. Bard | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Chinese PLA General Hospital | 1 |
| Foundation for Biomedical Research and Innovation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 37 |
| Angina Pectoris | 3 |
| Cardiovascular Diseases | 3 |
| Coronary Disease | 3 |
| Heart Diseases | 3 |
| Heart Failure | 3 |
| Myocardial Infarction | 3 |
| Cardiomyopathies | 2 |
| Heart Valve Diseases | 2 |
| Ischemia | 2 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.